A Study of Avastin (Bevacizumab) in Combination With Carboplatin-Based Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer.

NCT00700180 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

303

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: bevacizumab [Avastin]
DRUG: bevacizumab [Avastin]
DRUG: Carboplatin-based chemotherapy

Sponsor

Hoffmann-La Roche